Jennifer B. Damico - 03 Mar 2026 Form 4 Insider Report for PFIZER INC (PFE)

Role: SVP & Controller
Signature: /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico
Issuer symbol: PFE
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 17:27:54 UTC
Previous filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
DAMICO JENNIFER B.	SVP & Controller	66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK	/s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico	05 Mar 2026	0001805617

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Award		+16,311	+135%	$0.000000^*	28,352	03 Mar 2026	Direct	F1
transaction	PFE	Common Stock	Award		+5,408	+19%	$0.000000^*	33,760	03 Mar 2026	Direct	F1
transaction	PFE	Common Stock	Tax liability		-826	-2.4%	$26.62^*	32,934	04 Mar 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award		+22,638		$0.000000^*	22,638	03 Mar 2026	Common Stock	22,638	$26.58	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.